{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:56:30Z","timestamp":1790693790088,"version":"4.1.0"},"reference-count":44,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/113014\/2015"],"award-info":[{"award-number":["SFRH\/BPD\/113014\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Constitutional epimutation of the two major mismatch repair genes, <jats:italic><jats:styled-content style=\"fixed-case\">MLH<\/jats:styled-content>1<\/jats:italic> and <jats:italic><jats:styled-content style=\"fixed-case\">MSH<\/jats:styled-content>2<\/jats:italic>, has been identified as an alternative mechanism that predisposes to the development of Lynch syndrome. In the present work, we aimed to investigate the prevalence of <jats:italic><jats:styled-content style=\"fixed-case\">MLH<\/jats:styled-content>1<\/jats:italic> constitutional methylation in colorectal cancer (<jats:styled-content style=\"fixed-case\">CRC<\/jats:styled-content>) patients with abnormal expression of the <jats:styled-content style=\"fixed-case\">MLH<\/jats:styled-content>1 protein in their tumors. In a series of 38 patients who met clinical criteria for Lynch syndrome genetic testing, with loss of <jats:styled-content style=\"fixed-case\">MLH<\/jats:styled-content>1 expression in the tumor and with no germline mutations in the <jats:italic><jats:styled-content style=\"fixed-case\">MLH<\/jats:styled-content>1<\/jats:italic> gene (35\/38) or with tumors presenting the <jats:italic><jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content><\/jats:italic> p.Val600Glu mutation (3\/38), we screened for constitutional methylation of the <jats:italic><jats:styled-content style=\"fixed-case\">MLH<\/jats:styled-content>1<\/jats:italic> gene promoter using methylation\u2010specific multiplex ligation\u2010dependent probe amplification (<jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">MLPA<\/jats:styled-content>) in various biological samples. We found four (4\/38; 10.5%) patients with constitutional methylation in the <jats:italic><jats:styled-content style=\"fixed-case\">MLH<\/jats:styled-content>1<\/jats:italic> gene promoter. <jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> studies demonstrated decreased <jats:italic><jats:styled-content style=\"fixed-case\">MLH<\/jats:styled-content>1<\/jats:italic> expression in the cases with constitutional methylation when compared with controls. We could infer the mosaic nature of <jats:italic><jats:styled-content style=\"fixed-case\">MLH<\/jats:styled-content>1<\/jats:italic> constitutional hypermethylation in tissues originated from different embryonic germ layers, and in one family we could show that it occurred de novo. We conclude that constitutional <jats:italic><jats:styled-content style=\"fixed-case\">MLH<\/jats:styled-content>1<\/jats:italic> methylation occurs in a significant proportion of patients who have loss of <jats:styled-content style=\"fixed-case\">MLH<\/jats:styled-content>1 protein expression in their tumors and no <jats:italic><jats:styled-content style=\"fixed-case\">MLH<\/jats:styled-content>1<\/jats:italic> pathogenic germline mutation. Furthermore, we provide evidence that <jats:italic><jats:styled-content style=\"fixed-case\">MLH<\/jats:styled-content>1<\/jats:italic> constitutional hypermethylation is the molecular mechanism behind about 3% of Lynch syndrome families diagnosed in our institution, especially in patients with early onset or multiple primary tumors without significant family history.<\/jats:p>","DOI":"10.1002\/cam4.1285","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T06:46:10Z","timestamp":1516171570000},"page":"433-444","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Contribution of <i><scp>MLH<\/scp>1<\/i> constitutional methylation for Lynch syndrome diagnosis in patients with tumor <scp>MLH<\/scp>1 downregulation"],"prefix":"10.1002","volume":"7","author":[{"given":"Diana","family":"Pinto","sequence":"first","affiliation":[{"name":"Cancer Genetics Group IPO Porto Research Center (CI\u2010IPOP) Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"},{"name":"Department of Genetics Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Pinto","sequence":"additional","affiliation":[{"name":"Cancer Genetics Group IPO Porto Research Center (CI\u2010IPOP) Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"},{"name":"Department of Genetics Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Guerra","sequence":"additional","affiliation":[{"name":"Cancer Genetics Group IPO Porto Research Center (CI\u2010IPOP) Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"},{"name":"Department of Genetics Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Pinheiro","sequence":"additional","affiliation":[{"name":"Cancer Genetics Group IPO Porto Research Center (CI\u2010IPOP) Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"},{"name":"Department of Genetics Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Santos","sequence":"additional","affiliation":[{"name":"Cancer Genetics Group IPO Porto Research Center (CI\u2010IPOP) Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"},{"name":"Department of Genetics Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege Marie","family":"Vedeld","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology Institute for Cancer Research Oslo University Hospital  Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeremariam","family":"Yohannes","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology Institute for Cancer Research Oslo University Hospital  Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Peixoto","sequence":"additional","affiliation":[{"name":"Cancer Genetics Group IPO Porto Research Center (CI\u2010IPOP) Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"},{"name":"Department of Genetics Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Santos","sequence":"additional","affiliation":[{"name":"Cancer Genetics Group IPO Porto Research Center (CI\u2010IPOP) Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"},{"name":"Department of Genetics Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Pinto","sequence":"additional","affiliation":[{"name":"Cancer Genetics Group IPO Porto Research Center (CI\u2010IPOP) Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"},{"name":"Department of Genetics Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Lopes","sequence":"additional","affiliation":[{"name":"Department of Pathology Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"},{"name":"Cancer Biology and Epigenetics Group IPO Porto Research Center (CI\u2010IPOP) Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnhild","family":"Lothe","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology Institute for Cancer Research Oslo University Hospital  Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guro Elisabeth","family":"Lind","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology Institute for Cancer Research Oslo University Hospital  Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[{"name":"Department of Pathology Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"},{"name":"Cancer Biology and Epigenetics Group IPO Porto Research Center (CI\u2010IPOP) Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"},{"name":"Institute of Biomedical Sciences Abel Salazar (ICBAS) University of Porto  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4896-5982","authenticated-orcid":false,"given":"Manuel R.","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Cancer Genetics Group IPO Porto Research Center (CI\u2010IPOP) Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"},{"name":"Department of Genetics Portuguese Oncology Institute of Porto (IPO Porto)  Porto Portugal"},{"name":"Institute of Biomedical Sciences Abel Salazar (ICBAS) University of Porto  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.12.027"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21220"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.01.054"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1593107"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3878"},{"key":"e_1_2_7_7_1","first-page":"12","article-title":"Practical genetics of colorectal cancer","volume":"2","author":"Lynch H. T.","year":"2013","journal-title":"Chin. Clin Oncol."},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.09.003"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa064522"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2009.068122"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103076"},{"key":"e_1_2_7_12_1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.22785","article-title":"Lynch syndrome associated with two MLH1 promoter variants and allelic imbalance of MLH1 expression","volume":"36","author":"Hesson L. B.","year":"2014","journal-title":"Hum. Mutat."},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.283"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-013-9613-3"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20842"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2011.01660.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-180"},{"key":"e_1_2_7_18_1","first-page":"532","article-title":"A reagent for the single\u2010step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples","volume":"15","author":"Chomczynski P.","year":"1993","journal-title":"Biotechniques"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600148"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086657"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.082933"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30796"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-85"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.109"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki987"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2012.136"},{"key":"e_1_2_7_27_1","first-page":"5248","article-title":"A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer","volume":"58","author":"Boland C. R.","year":"1998","journal-title":"Can. Res."},{"key":"e_1_2_7_28_1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/gim.2012.91","article-title":"Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry","volume":"15","author":"Ward R. L.","year":"2012","journal-title":"Genet. Med."},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21617"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2008.25"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22168"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.1484"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2013.200"},{"key":"e_1_2_7_34_1","first-page":"3925","article-title":"A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability\u2010high tumor","volume":"62","author":"Gazzoli I.","year":"2002","journal-title":"Can. Res."},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25422"},{"key":"e_1_2_7_36_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0013314","article-title":"Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI\u2010H colorectal cancer","volume":"5","author":"Mrkonjic M.","year":"2010","journal-title":"PLoS ONE"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.064"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2010.12.004"},{"key":"e_1_2_7_39_1","first-page":"676","article-title":"Implications of mismatch repair\u2010deficient status on management of early stage colorectal cancer","volume":"6","author":"Kawakami H.","year":"2015","journal-title":"J. Gastrointest. Oncol."},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60353-4"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.020651"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-009-9302-4"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.04.001"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2011-100714"},{"key":"e_1_2_7_45_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10689-016-9926-0","article-title":"Performance of lynch syndrome predictive models in quantifying the likelihood of germline mutations in patients with abnormal MLH1 immunoexpression","volume":"16","author":"Cabreira V.","year":"2017","journal-title":"Fam. Cancer"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcam4.1285","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.1285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T03:54:33Z","timestamp":1695786873000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.1285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1002\/cam4.1285"],"URL":"https:\/\/doi.org\/10.1002\/cam4.1285","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"assertion":[{"value":"2016-08-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-11-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}